Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

Daniels, K; van der Nat, PB; Frequin, STFM; van der Wees, PJ; Biesma, DH; Hoogervorst, ELJ; van de Garde, EMW

MULTIPLE SCLEROSIS INTERNATIONAL, 2020; 2020 ():

Abstract

Background. Recently, ocrelizumab (Ocrevus (R)) was approved for the treatment of primary progressive multiple sclerosis (PPMS) based on data from the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索